Trial Profile
A Randomized, Double-blind, Placebo-controlled Trial Investigating the Effects of Levetiracetam in Early Psychosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Nov 2022
Price :
$35
*
At a glance
- Drugs Levetiracetam (Primary)
- Indications Psychotic disorders; Schizoaffective disorder; Schizophrenia
- Focus Pharmacodynamics
- 10 Aug 2022 Status changed from recruiting to completed.
- 02 Aug 2021 Planned End Date changed from 30 Dec 2020 to 22 Mar 2022.
- 02 Aug 2021 Planned primary completion date changed from 30 Dec 2020 to 22 Mar 2022.